Figure 1.
Percentage of patients prescribed a gastroprotective strategy per year for each upper gastrointestinal event risk group (as defined separately for each cohort). LDA, low-dose aspirin; NSAID, UGIE, upper gastrointestinal event
Percentage of patients prescribed a gastroprotective strategy per year for each upper gastrointestinal event risk group (as defined separately for each cohort). LDA, low-dose aspirin; NSAID, UGIE, upper gastrointestinal event